Novolog 100 unit/ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FKNGX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,890
Award facts
- Contract value 100% obligated
- $2,890.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,890.32 to AmerisourceBergen Drug Corp for the supply of NovoLog 100 Unit/mL vials (10mL units). This contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply medications, vaccines, and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and related military healthcare programs. The company holds significant capacity to fulfill federal pharmaceutical requirements through competitive procurement, as evidenced by its extensive portfolio of delivery orders covering diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This NovoLog insulin delivery is consistent with AmerisourceBergen's role in supporting the military's medical supply chain and demonstrates its capability to fulfill specialized pharmaceutical needs for federal health systems serving military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DB25FKNGX?
SPE2DB25FKNGX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FKNGX worth?
The government has obligated $2,890 on SPE2DB25FKNGX.
Is contract SPE2DB25FKNGX an order under another contract?
Yes. SPE2DB25FKNGX is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKNGX competed?
The extent of competition for SPE2DB25FKNGX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award